![Constantine Chinoporos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Constantine Chinoporos
Direktör/Styrelseledamot på
GERON CORPORATION
Förmögenhet: - $ per 2026-06-30
Profil
Mr. Constantine Chinoporos is on the Board of Directors at Geron Corp.
and Halozyme Hypercon, Inc. Mr. Chinoporos was previously employed as a Chief Operating & Business Officer by Applied Therapeutics, Inc., a Chief Business Officer by Albireo Pharma, Inc., a Chief Business Officer by Boston Pharmaceuticals, Inc., and a Head-Corporate Development by Genzyme Corp.
He received his undergraduate degree from Cornell University and an MBA from Johnson Graduate School of Management.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines -.--% | 2026-07-16 | 0 ( -.--% ) | - $ | 2026-06-30 |
Aktiva positioner av Constantine Chinoporos
| Företag | Position | Start |
|---|---|---|
| GERON CORPORATION | Direktör/Styrelseledamot | 2026-03-25 |
Elektrofi, Inc.
 Elektrofi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company with a breakthrough ultra-high concentration microparticle technology for biologics | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Constantine Chinoporos
| Företag | Position | Slut |
|---|---|---|
| APPLIED THERAPEUTICS, INC. | Verksamhetschef | 2026-02-03 |
| ALBIREO PHARMA, INC. | Företagsledare/Principal | 2023-03-01 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Företagsledare/Principal | 2021-10-01 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Företagsledare/Principal | - |
Constantine Chinopoross utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
52
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Commercial Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Applied Therapeutics, Inc.
 Applied Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative drugs and technologies for debilitating diseases | Health Technology |
Elektrofi, Inc.
Elektrofi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company with a breakthrough ultra-high concentration microparticle technology for biologics | Commercial Services |
